CLINICAL_TRIALS
trial_result
· 2019-01-16
Clinical Trial Update: Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain [Phase 3]
Summary
Phase 3 clinical trial of YHD1119 in peripheral neuropathic pain has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yuhan Corporation | Conditions: Peripheral Neuropathic Pain | Phase 3 | Status: COMPLETED